Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa
- PMID: 28545720
- PMCID: PMC5740483
- DOI: 10.1016/S1473-3099(17)30300-6
Effect of a vaccine to prevent serogroup A N meningitidis epidemics in Africa
Comment on
-
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22. Lancet Infect Dis. 2017. PMID: 28545721
References
-
- Greenwood B. Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg. 1999;93:341–53. - PubMed
-
- Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(suppl 2):B3–9. - PubMed
-
- Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A. Costs and impact of meningitis epidemics for the public health system in Burkina Faso. Vaccine. 2011;29:5474–80. - PubMed
-
- Colombini A, Bationo F, Zongo S, et al. Costs for households and community perception of meningitis epidemics in burkina faso. Clin Infect Dis. 2009;49:1520–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources